NCT05315791

Brief Summary

Through randomized controlled trials, investigators will recruit participants who need maxillary sinus floor elevation with different residual bone height, and utilize the maxillary sinus buccal bony window during the surgery. Then investigators will gather the related information of participants, collect and analyze their CBCT data, in order to help surgeons select the best operating method for different patients.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
81mo left

Started Mar 2022

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress38%
Mar 2022Dec 2032

Study Start

First participant enrolled

March 10, 2022

Completed
2 days until next milestone

First Submitted

Initial submission to the registry

March 12, 2022

Completed
26 days until next milestone

First Posted

Study publicly available on registry

April 7, 2022

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 2, 2023

Completed
9.8 years until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2032

Expected
Last Updated

April 7, 2022

Status Verified

March 1, 2022

Enrollment Period

12 months

First QC Date

March 12, 2022

Last Update Submit

March 30, 2022

Conditions

Keywords

maxillary sinus floor elevationCBCTRCT

Outcome Measures

Primary Outcomes (3)

  • ABH change

    Apical bone height (ABH): Represented the grafted height at baseline and the grafted height with neo-formed bone at follow-ups.

    baseline, 6 months, and 1, 2, 3, 5, 10 years after the surgery

  • ESBG change

    Endo-sinus bone gain (ESBG): ESBG = ABH + implant protrusion length at baseline; ESBG represented the grafted height and neo-formed bone, and described the height difference of radiopaque area in the sinus cavity at different times.

    baseline, 6 months, and 1, 2, 3, 5, 10 years after the surgery

  • RBH

    Residual bone height (RBH): Only assessed at baseline

    baseline

Study Arms (6)

a: ground into pieces

EXPERIMENTAL

0\~3mm

Procedure: different methods for maxillary sinus floor elevation

b: replace the bone

EXPERIMENTAL

0\~3mm

Procedure: different methods for maxillary sinus floor elevation

c: turn inward

EXPERIMENTAL

0\~3mm

Procedure: different methods for maxillary sinus floor elevation

d: ground into pieces

EXPERIMENTAL

3\~5mm

Procedure: different methods for maxillary sinus floor elevation

e: replace the bone

EXPERIMENTAL

3\~5mm

Procedure: different methods for maxillary sinus floor elevation

f: turn inward

EXPERIMENTAL

3\~5mm

Procedure: different methods for maxillary sinus floor elevation

Interventions

a: 0\~3mm+ground into pieces; b: 0\~3mm+replace the bone; c: 0\~3mm+turn inward to hold up the membrane; d: 3\~5mm+ground into pieces; e: 3\~5mm+replace the bone; f: 3\~5mm+turn inward to hold up the membrane

a: ground into piecesb: replace the bonec: turn inwardd: ground into piecese: replace the bonef: turn inward

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • A single maxillary posterior tooth was missing, and the missing time was ≥ 3 months
  • Gingival distance ≥ 4mm
  • Residual bone height ≤ 5mm and residual bone width ≥ 6mm
  • Good systemic health
  • CBCT image was complete and clear, and there was no obvious artifact affecting the measurement
  • Informed consent.

You may not qualify if:

  • Untreated diabetes or other serious systemic diseases
  • Untreated periodontal disease
  • Uncontrolled periapical lesions of adjacent teeth
  • Certain bone diseases such as osteoporosis and osteosclerosis
  • Severe night bruxism
  • Mental illness
  • Pregnant or breast-feeding patients.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

The Affiliated Hospital of Stomatology, Zhejiang University School of Medicine

Hangzhou, Zhejiang, China

RECRUITING

Related Publications (3)

  • Starch-Jensen T, Jensen JD. Maxillary Sinus Floor Augmentation: a Review of Selected Treatment Modalities. J Oral Maxillofac Res. 2017 Sep 30;8(3):e3. doi: 10.5037/jomr.2017.8303. eCollection 2017 Jul-Sep.

  • Niu L, Wang J, Yu H, Qiu L. New classification of maxillary sinus contours and its relation to sinus floor elevation surgery. Clin Implant Dent Relat Res. 2018 Aug;20(4):493-500. doi: 10.1111/cid.12606. Epub 2018 Apr 25.

  • Zhou Y, Shi Y, Si M, Wu M, Xie Z. The comparative evaluation of transcrestal and lateral sinus floor elevation in sites with residual bone height </=6 mm: A two-year prospective randomized study. Clin Oral Implants Res. 2021 Feb;32(2):180-191. doi: 10.1111/clr.13688. Epub 2020 Dec 26.

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Director

Study Record Dates

First Submitted

March 12, 2022

First Posted

April 7, 2022

Study Start

March 10, 2022

Primary Completion

March 2, 2023

Study Completion (Estimated)

December 31, 2032

Last Updated

April 7, 2022

Record last verified: 2022-03

Data Sharing

IPD Sharing
Will not share

Locations